Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models

Breast

Volumn 21, Issue 2, 2012, Pages 204-209

  Houvenaeghel, Gilles ^a   Bannier, Marie ^a   Nos, Claude ^b   Giard, Sylvia ^c   Mignotte, Herve ^d   Jacquemier, Jocelyne ^a   Martino, Marc ^a   Esterni, Benjamin ^a   Belichard, Catherine ^e   Classe, Jean Marc ^f   Tunon de Lara, Christine ^g   Cohen, Monique ^h   Payan, Raoul ⁱ   Blanchot, Jerome ^j   Rouanet, Philippe ^k   Penault Llorca, Frederique ^l   Bonnier, Pascal ^m   Fournet, Sandrine ⁿ   Agostini, Aubert ^m   Marchal, Frederique ^o   Garbay, Jean Remi ^p   more..

^a INSTITUT PAOLI CALMETTES   (France)

^b INSTITUT CURIE   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d CENTRE LÉON BÉRARD   (France)

^e CENTRE RENÉ HUGUENIN   (France)

^f CENTRE RENÉ GAUDUCHEAU   (France)

^g INSTITUT BERGONIÉ   (France)

^h La Casamance   (France)

ⁱ Centre Eugène Marquis ^*

^j CENTRE EUGÈNE MARQUIS   (France)

^k CENTRE VAL D AURELLE   (France)

^l CENTRE JEAN PERRIN   (France)

^m Les Diaconnesses   (France)

ⁿ Centre Alexis Vautrin   (France)

^o CENTRE ALEXIS VAUTRIN   (France)

^p INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

Breast cancer; Micrometastasis; Nomogram; Non sentinel lymph node; Prediction; Sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER PROGNOSIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MULTIVARIATE ANALYSIS; NOMOGRAM; NON SENTINEL LYMPH NODE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; STAINING; TUMOR VOLUME; VALIDATION STUDY;

EID: 84858747420     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.09.013     Document Type: Article

References (28)

1. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., Boolbol Susan K., Fey Jane V., Tan Lee K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10:1140-1151.
2. Degnim A.C., Reynolds C., Pantvaidya G., Zakaria S., Hoskin T., Barnes S., et al. Non sentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005, 190:543-550.
3. Pal A., Provenzano E., Duffy S.W., Pinder S.E., Purushotham A.D. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008, 95:302-309.
4. Kohrt H.E., Olshen R.A., Bermas H.R., Goodson W.H., Wood D.J., Henry S., et al. New models and online calcutor for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008, 8:66.
5. Hwang R.F., Krishnamurthy S., Hunt K.K., Mirza N., Ames F.C., Feig B., et al. Clinicopathologic factors predicting involvement of non sentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003, 10:248-254.
6. Saidi R.F., Dudrick P.S., Remine S.G., Mittal V.K. Non sentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004, 70:101-105.
7. Barranger E., Coutant C., Flahault A., Delpech Y., Darai E., Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005, 91:113-119.
8. Houvenaeghel G., Nos C., Giard S., Mignotte H., Esterni B., Jacquemier J., et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009, 35:690-695.
9. Houvenaeghel G., Nos C., Mignotte H., Giard S., Esterni B., Jacquemier J., et al. Micrometastasis in sentinel lymph node in a multicentric study: predictive factors of non sentinel lymph node involvement - Groupe des chirurgiens de la federation des centres de lutte contre le cancer. J Clin Oncol 2006, 24:1814-1822.
10. Kim T., Giuliano A.E., Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta analysis. Cancer 2006, 106:4-16.
11. Lyman G.H., Giuliano A.E., Somerfield M.R., Benson A.B., Bodurka D.C., Burstein H.J., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005, 23:7703-7720.
12. Coutant C., Olivier C., Fondrinier E., et al. Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 2009, 27:2800-2808.
13. Ponzone R., Maggiorotto F., Mariani L., Jacomuzzi M.E., Magistris A., Mininanni P., et al. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 2007, 193:686-692.
14. Alran S., De Rycke Y., Fourchotte V., Charitansky H., Laki F., Falcou M.C., et al. Validation and limitations of use of a breast cancer nomogram predicting the likehood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007, 14:2195-2201.
15. Klar M., Jochmann A., Foeldi M., Stumpf M., Gitsch G., Stickeler E., et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 2008, 112:523-531.
16. Specht M.C., Kattan M.W., Gonen M., Fey J., Van Zee K.J. Predicting non sentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005, 12:654-659.
17. Maibenco D.C., Dombi G.W., Kau T.Y., Severson R.K. Significance of micrometastasis on the survival of women with T1 breast cancer. Cancer 2006, 107:1234-1239.
18. Querzoli P., Pedriali M., Rinaldi R., Lombardi A.R., Biganzoli E., Boracchi P., et al. Axillary lymph node nanometastasis are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 2006, 12:6696-6701.
19. Hansen N.M., Grube B.J., Te W., Brennan M.L., Turner R., Giuliano A.E., et al. Clinical significance of axillary micrometastasis in breast cancer: how small is to small?. Proc Am Soc Clin Oncol 2001, 20:91a.
20. Cox C., Vrcel V., Riker A., Cox J.M., Ramos D.C., Allred N., et al. Significance of sentinel lymph node micrometastasis on survival for patients with invasive breast cancer. Breast Cancer Res Treat 2005, 94:S12-S13.
21. Chagpar A., Middleton L.P., Sahin A.A., Meric-Bernstam F., Kuerer H.M., Feig B.W., et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastasis detected by immunohistochemistry. Cancer 2005, 103:1581-1586.
22. Colleoni M., Rotmensz N., Peruzzotti G., Maisonneuve P., Mazzarol G., Pruneri G., et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005, 23:1379-1389.
23. Cox C.E., Kiluk J.V., Riker A.I., Cox J.M., Allred N., Ramos D.C., et al. Significance of sentinel lymph node micrometastasis in human breast cancer. J Am Coll Surg 2008, 206:261-268.
24. Gobardhan P.D., Elias S.G., Madsen E.V., Bongers V., Ruitenberg H.J., Perre C.I., et al. Prognostic value of micrometastasis in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 2008, 20:41-48.
25. Grabau D., Jensen M.B., Rank F., Blichert-Toft M.I. Axillary lymph node micrometastasis in invasive breast cancer: national figures on incidence and overall survival. APMIS 2007, 115:828-837.
26. Chen S.L., Hoehne F.M., Giuliano A.E. The prognostic significance of micrometastasis in breast cancer: a SEER population-based analysis. Ann Surg Oncol 2007, 14:3378-3384.
27. De Boer M., Van Deurzen C.H., Van Dijck J.A., Borm G.F., van Diest P.J., Adang E.M., et al. Micrometastasis or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009, 361:653-663.
28. Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575.